Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03363126

Acronym

RetroADEN

Enrollment

Registered

2017-12-06

Start date

2015-09-01

Completion date

2016-06-20

Last updated

2017-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optic Chiasm Disorder, Pituitary Tumor

Brief summary

Endoscopic endonasal transsphenoidal surgery is a procedure for the treatment of pituitary macroadenomas that cause visual impairment through optic chiasm compression. The aim of this retrospective study is to describe visual outcome after this procedure.

Interventions

PROCEDUREEndonasal transsphenoidal pituitary tumor removal

Removal of pituitary tumor by transsphenoidal endonasal surgery

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Pituitary tumor causing optic chiasm compression (documented on MRI or CT-scan) * Visual impairment caused by chiasm compression * Treatment by transsphenoidal endonasal surgery * Treatment in the Rothschild Foundation (Paris) between 2009 and 2013

Exclusion criteria

* Ophtalmologic condition other than optic chiasm compression

Design outcomes

Primary

Measure	Time frame	Description
Post-operative gain in visual acuity	six months	Difference between pre-operative and post-operative visual acuity, expressed in LogMAR

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026